Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients

Clinical and Experimental Allergy

Volumn 27, Issue 4, 1997, Pages 396-405

  Teran, L M ^a   Campos, M G ^a   Begishvilli, B T ^a   Schroder J M ^b   Djukanovic, R ^a   Shute, J K ^a   Church, M K ^a   Holgate, S T ^a,c   Davies, D E ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b UNIVERSITY OF KIEL   (Germany)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Asthma; C5a des Arg; Chemotaxis; IL 8; Neutrophils

Indexed keywords

CHEMOTACTIC FACTOR; COMPLEMENT COMPONENT C5A; INTERLEUKIN 8;

ADULT; ARTICLE; ASTHMA; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0030945403     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.1997.tb00724.x     Document Type: Article

References (44)

1. Mattoli S, Mattoso VL, Soloperto M, Allegra L, Fasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic and nonallergic asthma. J Allergy Clin Immunol 1991: 4:794-802.
2. Sur S, Crotty TB, Kephart GM et al. Sudden-onset fatal asthma. A distinct entitity with few eosinophils and relatively more neutrophils in the airway submucosa. Am Rev Respir Dis 1993; 148:713-9.
3. Metzger WJ, Richerson HB, Worden K, Monick M, Hunninghake GW. Bronchoalveolar lavage of allergic asthmatic patients following allergen provocation. Chest 1986; 89:477-83.
4. Fabbri LM, Boschetto P, Zocca E et al. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis 1987; 136:36-42.
5. Henson PM, Johnston RB. Tissue injury in inflammation: oxidants, proteinases and cationic proteins. J Clin Invest 1987; 79:669-74.
6. Lotner GZ, Lynch JM, Betz SJ, Henson PM. Human neutrophil-derived platelet-activating factor. J Immunol 1980; 124:676-84.
7. Crea AEG, Nakhosteen JA, Lee TH. Mediator concentrations in bronchoalveolar lavage fluid of patients with mild asymptomatic bronchial asthma. Eur Respir J 1992; 5:190-5.
8. Kew RR, Webster RO. Gc-globulin (Vitamin-D binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 1988; 82:364-9.
9. Teran LM, Davies DE. The chemokines: their potential role in allergic inflammation. Clin Exp Allergy 1996; 26:1005-19.
10. Schröder J, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived neutrophil-activating peptide that lacks interleukin-1 activity. J Immunol 1987; 139:3474-83.
11. Sylvester I, Rankin JA, Yoshimura T, Tanaka S, Leonard EJ. Secretion of neutrophil attractant/activation protein by lipopolysaccharide-stimulated lung macrophages determined by both enzyme-linked immunosorbent assay and N-terminal sequence analysis. Am Rev Respir Dis 1990; 141:683-8.
12. Möller A, Lippert U, Lessmann D et al. Human mast cells produce interleukin-8. 151 1993; 151:3261-6.
13. Schröder J, Cristophers E. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 1989; 142:244-51.
14. Nakamura HY, Yoshimura K, Jaffe HA, Crystal RG. Interleukin-8 gene expression in human bronchial epithelial cells. J Biol Chem 1991; 266:19611-7.
15. Persson CGA. Plasma exudation in the airways, mechanisms and function. Eur Respir J 1991; 4:1269-74.
16. Proud D, Siekierski ES, Bailey GS. Identification of human lung mast cell kininogenase as tryptase and relevance of tryptase kininogenase activity. Biochem Pharmacol 1988; 37:1473-80.
17. National Heart, Lung and Blood Institute. Workshop summary and guidelines: investigative use of bronchochopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 1992; 88:808-14.
18. Djukanović R, Wilson J, Lai C, Howarth PH, Holgate ST. The safety aspects of fibreoptic bronchoscopy lavage and endobronchial biopsy in asthma. Am Rev Respir Dis 1991; 143:772-7.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram qualities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:248-54.
20. Yoshimura TK, Matsushima K, Oppenheim JJ, Leonard EJ. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin-1 (JL-1). J Immunol 1987; 139:788-93.
21. Schröder J, Christophers E. Identification of C5a des Arg and an anionic neutrophil peptide (ANAP) in psoriatic scales. J Invest Dermatol 1986; 87:53-8.
22. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968; 21:77-89.
23. Harvard L, Falk W, Leonard EJ. Rapid quantification of neutrophil chemotaxis: use of polyvinylpyrrolidone-free polycarbonate membrane in a multiwell assambly. J Immunol Methods 1980; 37:39-45.
24. Chenoweth DE, Hugli TE. Techniques and significance of C3a and C5a measurement in 'future perspectives in clinical laboratory immunoassays'. In: Nakamura ed. New York: Alan R. Liss, 1980:
25. Ceska MF, Effenberger F, Piechel P, Pursh E. Purification and characterization of monoclonal and polyclonal antibodies to neutrophil activating peptide (NAP-1): the development of highly sensitive ELISA method for the determination of NAP-1 and anti-NAP-1 antibodies. Cytokines 1989; 1:136 (abstract).
26. Wardlaw AJ, Hay H, Cromwell O, Collins JV, Kay AB. Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. J Allergy Clin Immunol 1989; 84:19-26.
27. Yousefi S, Haemman S, Weber M et al. IL-8 is expressed by human peripheral blood eosinophils: evidence for increased secretion in asthma. J Immunol 1995; 154:5481-90.
28. Craig G, Hugli TE. Identification of classical anaphylatoxin as the des Arg form of the C5a molecule: evidence of a modulator role for the oligosaccharide unit in human des Arg C5a. Proc Natl Acad Sci USA 1981; 78:1833-7.
29. Kurdoswka A, Cohen AB, Baughman RP. Alpha-2 macroglobulin: IL-8 complexes and anti-IL-8 antibody: IL-8 complexes in the bronchoalveolar lavage fluid of patients with adult respiratory syndrome. Am Rev Respir Dis 1994; 149:358 (abstract).
30. Borth W. α2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 1995; 6:3345-53.
31. Metzger WJ, Richerson HB, Wasserman SI. Generation and partial characterisation of eosinophil chemotactic activity and neutrophil chemotactic activity during early and latephase asthmatic responses. J Allergy Clin Immunol 1986; 78:282-90.
32. Towes GB, Vial WC. The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumonia. Am Rev Respir Dis 1987; 136:225-44.
33. Fick RB, Robbins RAJ, Squirre SU, Schroderbek WE, Russ WD. Complement activation in cystic fibrosis respiratory fluid: in vivo and in vitro generation of C5a chemotactic activity. Pediatr Respir 1986; 20:1258-68.
34. Ozaki T, Hayashi KT, Tani K et al. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992; 145:85-91.
35. Erjefalt J, Persson CGA. Anti-asthma drugs attenuate inflammatory leakage of plasma into airway lumen. Acta Physiol Scand 1986; 128:653-4.
36. Proud D, Togias A, Naclerio RM, Crush SA, Norman PS, Lichtenstein LM. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983; 72:1678-85.
37. Hugli RE, Muller-Eberhard HJ. Anaphylotoxins: C3a and C5a. Adv Immunol 1978; 26:1-53.
38. Sylvester I, Yoshimura T, Sticherling M et al. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in human normal serum. J Clin Invest 1992; 90:471-81.
39. Teran LM. Determination of interleukin 8 in the bronchoalveolar lavage fluid from asthmatics and comparison to normal subjects. PhD thesis, 1995.
40. Walker C, Bauer W, Braun RK et al. Activated T cells and cytokines in bronchoalveolar lavage from patients with various lung diseases associated to eosinophilia. Am J Respir Crit Care Med 1994; 150:1038-48.
41. Stenton SC, Court EN, Kingston WP. Platelet-activating factor in bronchoalveolar lavage fluid from asthmatic subjects. Eur Respir J 1990; 3:408-13.
42. Walz A, Burgener R, Car B, Baggiolini M. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin-8. J Exp Med 1991; 174:1355-62.
43. Thomas HG, Han JH, Balentien E, Derynck R, Bordoni R, Richmond A. Purification and characterization of recombinant melanoma growth stimulating activity. Methods Enzymol 1991; 198:373-83.
44. Schröder J, Pearson NLM, Christophers E. Lipopolysaccharide-stimulated human monocytes secrete, apart from neutrophil-activating peptide 1/interleukin-8, a second neutrophil-activating protein. J Exp Med 1990; 171:1091-100.